For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240422:nRSV3813La&default-theme=true
RNS Number : 3813L Helios Underwriting Plc 22 April 2024
22 April 2024
Helios Underwriting plc
("Helios" or the "Company")
Directorate Change
Helios, the investment vehicle which builds shareholder value participating
across a spread of Lloyd's syndicates, announces that Edward Fitzalan-Howard,
Duke of Norfolk, has tendered his resignation as Non-Executive Director of the
Board with effect from 19 April 2024. The Board of Directors accepts and
respects his decision and expresses gratitude for his contributions throughout
his tenure with the Company.
As the Company develops its strategy, the appointment of additional
Non-Executive Directors is currently under consideration by the Board.
Michael Wade, Chairman and Non-Executive Director said: "On behalf of the
Board, I would like to thank the Duke of Norfolk for his service for over six
years at Helios Underwriting and note that His Grace intends to remain a
shareholder in the Company."
For further information, please contact:
Helios Underwriting plc
Martin Reith - Chief Executive Officer
+44 (0)203 965 6441
Nigel Hanbury - Executive Deputy Chairman
Arthur Manners - Chief Financial Officer
Deutsche Numis (Nomad and Broker)
Giles Rolls / Charles
Farquhar
+44 (0)20 7260 1000
Buchanan (PR)
Helen Tarbet / George Beale
+44 (0)7872 604
453
+44 (0)20 7466 5111
About Helios
Helios provides a limited liability direct investment into the Lloyd's
insurance market and is quoted on the London Stock Exchange's AIM market
(ticker: HUW). Helios trades within the Lloyd's insurance market writing
approximately £502m of capacity for the 2024 account. The portfolio provides
a good spread of business being concentrated in property & casualty
insurance and reinsurance. For further information please
visit www.huwplc.com (http://www.huwplc.com/) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAFZGMDFLFGDZM